ATC code M04

From Wikipedia, the free encyclopedia

ATC code M04 Antigout preparations is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup M04 is part of the anatomical group M Musculo-skeletal system.[4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QM04.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

M04A Antigout preparations[edit]

M04AA Preparations inhibiting uric acid production[edit]

M04AA01 Allopurinol
M04AA02 Tisopurine
M04AA03 Febuxostat
M04AA51 Allopurinol, combinations

M04AB Preparations increasing uric acid excretion[edit]

M04AB01 Probenecid
M04AB02 Sulfinpyrazone
M04AB03 Benzbromarone
M04AB04 Isobromindione
M04AB05 Lesinurad

M04AC Preparations with no effect on uric acid metabolism[edit]

M04AC01 Colchicine
M04AC02 Cinchophen
M04AC51 Colchicine and probenecid

M04AX Other antigout preparations[edit]

M04AX01 Urate oxidase
M04AX02 Pegloticase

References[edit]

  1. ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
  2. ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
  3. ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
  4. ^ "ATC/DDD Index 2022: code M04". WHO Collaborating Centre for Drug Statistics Methodology.
  5. ^ "ATCvet Index 2022: code QM04". WHO Collaborating Centre for Drug Statistics Methodology.